the dual microbial preparation contains the microscopic oomycete pythium oligandrum and components of a physiological microbiome . the microscopic oomycete pythium oligandrum and the physiological microbiome component are present in the dual preparation in a form which facilitates their germination , subsequent propagation and colonization of the target tissues . the microscopic oomycete pythium oligandrum is incorporated in a quantity of 10 3 to 10 7 cfu , with 10 4 to 10 5 cfu per one cycle of application preferably . the physiological microbiome component contains 5 × 10 6 to 5 × 10 10 cfu , with 5 × 10 7 to 5 × 10 9 per one cycle of application preferably . the fermented substrate found in the pythium oligandrum oomycete is the source of nutrients for both microbial components . the dual microbial preparation also contains at least one auxiliary substance from a group including a desiccant , components of a buffer system , an anti - caking substance and an agent for the creation of a physiological osmotic environment . the physiological microbiome component is a component of the human microbiome , one of the microbes of the green complex , such as the capnocytophaga sputigena bacterium , or one of the components of the healthy skin microbiome , such as the staphyloccocus epidermidis bacterium , or one of the components of the healthy vaginal microbiome , such as the peroxide producing lactobacillus crispatus . either the microscopic oomycete pythium oligandrum or the physiological microbiome component is present in the dual microbial preparation in the form of inactivated cells , cell extracts or isolated cell fractionation . the microbial activator for the pythium oligandrum oomycete is a yeast autolysate in a quantity of 0 . 1 % to 10 % weight of the total quantity of dual microbial preparation . the auxiliary substances are regulated in a way which allows for application in the form of an ointment , cream , oil or suppository or in the form of a liquid aqueous preparation .